- Gamida Cell (NASDAQ:GMDA) is 9.7% lower on a registration to offer $34.7M worth of shares.
- That comes via RBC Capital markets, JMP Securities and Oppenheimer.
- It expects net proceeds of about $27.7M (or $31.9M if underwriters exercise an overallotment option in full), to be used as follows: $15M-$20M to fund clinical development; about $5M-$10M to expand manufacturing, and the rest for general purposes.
Gamida Cell -9.7% on registration of $34.7M in shares
Recommended For You
More Trending News
About GMDA Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
GMDA | - | - |
Gamida Cell Ltd. |